Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).

for
Hematopoietic Cell Transplantation
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Duke University

Sex: All

Age: 0 - 26

Code: NCT05090345

Recruiting

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

for
Allogeneic Stell Cell Transplant, Viral Infection
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT04230356

Phase 2, Recruiting

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

for
Allogeneic Hematopoietic Cell Transplantation
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05501756

Phase 2, Recruiting

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

for
Acute Leukemia
Location: South Portland ME, Boston MA, The Bronx NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 2+

Code: NCT04811560

Phase 1, Phase 2, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

for
Acute Leukemia, Severe Aplastic Anemia, Non-hodgkin Lymphoma,
Location: Valhalla NY
Sponsor: Mitchell Cairo

Sex: All

Age: 0 - 30

Code: NCT04099966

Phase 2, Recruiting

MAGIC Ruxolitinib for aGVHD

for
Acute Graft-versus-host Disease,
Location: Boston MA, New York NY, Atlanta GA, Nashville TN,
Sponsor: John Levine

Sex: All

Age: 18+

Code: NCT06936566

Phase 2, Recruiting
New

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 21+

Code: NCT07737769

Phase 1, Recruiting

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

for
Recurrent Oligodendroglioma, Progressive Oligodendroglioma
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT06254326

Phase 1, Recruiting

Autologous Stem Cell Transplant for Crohn's Disease

for
Crohn Disease
Location: New York NY
Sponsor: Aaron Etra

Sex: All

Age: 18+

Code: NCT03219359

Phase 2, Recruiting

Baker Gordon Syndrome Natural History Study

for
Rare Diseases, Autism or Autistic Traits, Development Delay,
Location: Columbia MO
Sponsor: University of Missouri-Columbia

Sex: All

Age: 0 - 70+

Code: NCT06399952

Recruiting

Longitudinal Study of Neurodegenerative Disorders

for
MLD, Krabbe Disease, ALD, MPS I, MPS II, MPS III,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 0+

Code: NCT03333200

Recruiting

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

for
Neuroblastoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 30

Code: NCT02605421

Phase 2, Recruiting

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

for
Myelodysplastic/Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07228624

Phase 2, Recruiting

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

for
Chronic Pancreatitis, Chronic Pain
Location: Charleston SC
Sponsor: VA Office of Research and Development

Sex: All

Age: 18 - 70+

Code: NCT05925036

Phase 1, Recruiting

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

for
Systemic Lupus Erythematosus, Systemic Sclerosis
Location: Philadelphia PA
Sponsor: Stephan Grupp MD PhD

Sex: All

Age: 8 - 25

Code: NCT05029336

Phase 2, Recruiting

Auto Stem Cell Transplant for Lymphoma Patients

for
Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT03125642

Phase 2, Recruiting

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

for
Chronic Pancreatitis, Chronic Pain
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18 - 70+

Code: NCT06205342

Early Phase 1, Recruiting

Personalized Autologous Transplant for Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04483206

Phase 1, Recruiting

AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses

for
End Stage Renal Disease
Location: Jacksonville FL
Sponsor: Houssam Farres, M.D.

Sex: All

Age: 18 - 70+

Code: NCT04392206

Phase 1, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial